Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,186,600
in 2 filings

Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. PERRY MICHAEL S −$1.0M Director sold 9% of stake
  2. OLUKOTUN ADEOYE Y −$174K Director sold 6% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-01-01 GIVEN DOUGLAS B Director Grant or award +9,500 123,368
2021-01-01 Hamilton James C Senior Vice President Grant or award +50,000 175,000
2021-01-01 Waddill William D. Director Grant or award +9,000 34,000
2021-01-01 Anzalone Christopher Richard Chief Executive Officer Grant or award +800,000 3,344,022
2020-12-30 Anzalone Christopher Richard Chief Executive Officer Gift −599 2,544,022
2020-12-28 Anzalone Christopher Richard Chief Executive Officer Gift −1,126 2,544,621
2020-12-22 GIVEN DOUGLAS B Director Gift −35 113,868
2020-12-21 GIVEN DOUGLAS B Director Gift −200 113,938
2020-12-21 GIVEN DOUGLAS B Director Gift −35 113,903
2020-12-18 Anzalone Christopher Richard Chief Executive Officer Option exercise +12,236 $4.75 $58K 2,517,473
2020-12-18 Anzalone Christopher Richard Chief Executive Officer Option exercise +28,274 $6.15 $174K 2,545,747
2020-12-18 Anzalone Christopher Richard Chief Executive Officer Option exercise · Common Stock (right to buy) −12,236 828,307
2020-12-18 Anzalone Christopher Richard Chief Executive Officer Option exercise · Common Stock (right to buy) −28,274 800,033
2020-12-17 GIVEN DOUGLAS B Director Gift −65 114,673
2020-12-17 GIVEN DOUGLAS B Director Gift −65 114,608
2020-12-17 GIVEN DOUGLAS B Director Gift −200 114,408
2020-12-17 GIVEN DOUGLAS B Director Gift −200 114,208
2020-12-17 GIVEN DOUGLAS B Director Gift −35 114,173
2020-12-17 GIVEN DOUGLAS B Director Gift −35 114,138
2020-12-17 GIVEN DOUGLAS B Director Sale −9,075 $79.30 $720K 114,738

Page 20 of 38 · 752 trades